A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO)

Turner, Nicholas C.; Telli, Melinda L.; Rugo, Hope S.; Mailliez, Audrey; Ettl, Johannes; Grischke, Eva-Maria; Mina, Lida A.; Balmana, Judith; Fasching, Peter A.; Hurvitz, Sara A.; Wardley, Andrew M.; Chappey, Colombe; Hannah, Alison L.; Robson, Mark E.

dc.contributor.author	Grischke, Eva-Maria
dc.date.accessioned	2020-04-27T10:49:34Z
dc.date.available	2020-04-27T10:49:34Z
dc.date.issued	2019
dc.identifier.issn	1557-3265
dc.identifier.uri	http://hdl.handle.net/10900/99868
dc.language.iso	en	de_DE
dc.publisher	Amer Assoc Cancer Research	de_DE
dc.relation.uri	http://dx.doi.org/10.1158/1078-0432.CCR-18-1891	de_DE
dc.subject.ddc	610	de_DE
dc.title	A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO)	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_01529
utue.publikation.seiten	2717-2724	de_DE
utue.personen.roh	Turner, Nicholas C.
utue.personen.roh	Telli, Melinda L.
utue.personen.roh	Rugo, Hope S.
utue.personen.roh	Mailliez, Audrey
utue.personen.roh	Ettl, Johannes
utue.personen.roh	Grischke, Eva-Maria
utue.personen.roh	Mina, Lida A.
utue.personen.roh	Balmana, Judith
utue.personen.roh	Fasching, Peter A.
utue.personen.roh	Hurvitz, Sara A.
utue.personen.roh	Wardley, Andrew M.
utue.personen.roh	Chappey, Colombe
utue.personen.roh	Hannah, Alison L.
utue.personen.roh	Robson, Mark E.
dcterms.isPartOf.ZSTitelID	Clinical Cancer Research	de_DE
dcterms.isPartOf.ZS-Issue	9	de_DE
dcterms.isPartOf.ZS-Volume	25	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE